| Application no. and date | 15817743.6 (espacenet) (Federated) (European Patent Register), 20151215 | | Patent/reg. no. and date | DK/EP 3234132, 20190710 | | Publication date | 20171025 | | Priority no. and date | US 201462092241 P, 20141215, US 201462092238 P, 20141215, US 201562187856 P, 20150702, US 201562187848 P, 20150702 | | EP pub. no. and date |
EP 3234132 20171025 | | Effective date | | | Applicant/owner | Novo Nordisk A/S, Novo Allé 1, 2880 Bagsværd, DK | | Applicant ref. no. | | | Inventor | BROWN, Bob, Dale, 57 Grist Mill Road,
Littleton, MA 01460, US,
WANG, Weimin, Dicerna Pharaceuticals Inc.
87 Cambridgepark Drive
Cambridge, MA 02140, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | C12N 15/11 (2006.01) , C12N 15/113 (2010.01) | | Title | LIGAND-MODIFICEREDE DOBBELTSTRENGEDE NUKLEINSYRER | | Int. application no. | US2015065906 | | Int. publication no. | WO2016100401 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
